MEDIPOST Co., Ltd. (KOSDAQ:078160)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,000
+850 (7.62%)
Jun 19, 2025, 2:40 PM KST
79.91%
Market Cap 380.20B
Revenue (ttm) 71.85B
Net Income (ttm) -72.06B
Shares Out 34.10M
EPS (ttm) -2,113.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 193,727
Average Volume 104,959
Open 11,150
Previous Close 11,150
Day's Range 10,940 - 12,200
52-Week Range 5,450 - 15,180
Beta 0.38
RSI 64.43
Earnings Date Aug 14, 2025

About MEDIPOST

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 328
Stock Exchange KOSDAQ
Ticker Symbol 078160
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.